- Home
- TGI vs APGE Comparison
TGI vs APGE Comparison
Compare TGI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGI
- APGE
- Stock Information
- Founded
- TGI 1993
- APGE 2022
- Country
- TGI United States
- APGE United States
- Employees
- TGI N/A
- APGE N/A
- Industry
- TGI Aerospace
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TGI Industrials
- APGE Health Care
- Exchange
- TGI Nasdaq
- APGE Nasdaq
- Market Cap
- TGI 2.0B
- APGE 2.1B
- IPO Year
- TGI 1996
- APGE 2023
- Fundamental
- Price
- TGI $24.70
- APGE $33.11
- Analyst Decision
- TGI Hold
- APGE Strong Buy
- Analyst Count
- TGI 8
- APGE 4
- Target Price
- TGI $20.63
- APGE $91.33
- AVG Volume (30 Days)
- TGI 2.4M
- APGE 802.7K
- Earning Date
- TGI 05-22-2025
- APGE 05-12-2025
- Dividend Yield
- TGI N/A
- APGE N/A
- EPS Growth
- TGI N/A
- APGE N/A
- EPS
- TGI 7.25
- APGE N/A
- Revenue
- TGI $1,242,654,000.00
- APGE N/A
- Revenue This Year
- TGI $3.60
- APGE N/A
- Revenue Next Year
- TGI $10.85
- APGE $743.14
- P/E Ratio
- TGI $144.89
- APGE N/A
- Revenue Growth
- TGI 7.23
- APGE N/A
- 52 Week Low
- TGI $11.01
- APGE $26.20
- 52 Week High
- TGI $25.55
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- TGI 43.71
- APGE 45.63
- Support Level
- TGI $24.23
- APGE $31.38
- Resistance Level
- TGI $25.00
- APGE $34.23
- Average True Range (ATR)
- TGI 0.34
- APGE 3.28
- MACD
- TGI -0.08
- APGE -0.18
- Stochastic Oscillator
- TGI 39.29
- APGE 54.22
About TGI Triumph Group Inc.
Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.